Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
90
PEN Quote, Financials, Valuation and Earnings
Last price:
$350.51
Seasonality move
:
7.09%
Day range:
$345.20 - $352.15
52-week range:
$221.26 - $352.15
Dividend yield:
0%
P/E ratio:
83.76x
P/S ratio:
10.30x
P/B ratio:
10.10x
Volume:
9.7M
Avg. volume:
841.9K
1-year change:
33.89%
Market cap:
$13.7B
Revenue:
$1.2B
EPS (TTM):
$4.18
Earnings Data
Next earnings date for PEN
Feb 17
2026
Most recent earnings per share
$1.17
Beat by $0.25
(Nov 5/2025)
Consensus Estimate
$0.92
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PEN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $370.3M | -- | -- | $1.09 | -- |
| 02/17/2026 | Q4 | $363.1M | -- | -- | $1.10 | -- |
| 11/05/2025 | Q3 | $340.7M | $354.7M | $1.17 | $0.92 | $0.25 |
| 07/29/2025 | Q2 | $327.4M | $339.5M | $1.15 | $0.82 | $0.33 |
| 04/23/2025 | Q1 | $315.7M | $324.1M | $1.00 | $0.67 | $0.33 |
| 02/18/2025 | Q4 | $311.6M | $315.5M | $0.86 | $0.89 | -$0.03 |
| 10/30/2024 | Q3 | $297.4M | $301M | $0.75 | $0.69 | $0.07 |
| 07/30/2024 | Q2 | $297.9M | $299.4M | -$1.55 | $0.56 | -$2.11 |
| 05/07/2024 | Q1 | $274.5M | $278.7M | $0.28 | $0.38 | -$0.10 |
| 02/22/2024 | Q4 | $286.5M | $284.7M | $1.38 | $0.70 | $0.68 |
| 11/02/2023 | Q3 | $265.1M | $270.9M | $0.23 | $0.45 | -$0.22 |
| 08/01/2023 | Q2 | -- | $261.5M | $0.48 | -- | -- |
| 05/02/2023 | Q1 | -- | $241.4M | $0.22 | -- | -- |
| 02/23/2023 | Q4 | -- | $221.2M | $0.10 | -- | -- |
| 11/03/2022 | Q3 | -- | $213.7M | -$0.06 | -- | -- |
| 08/04/2022 | Q2 | -- | $208.3M | -$0.10 | -- | -- |
| 05/03/2022 | Q1 | -- | $203.9M | $0.00 | -- | -- |
| 02/22/2022 | Q4 | -- | $204M | -$0.66 | -- | -- |
| 11/03/2021 | Q3 | -- | $190.1M | $0.24 | -- | -- |
| 08/09/2021 | Q2 | -- | $184.3M | $0.25 | -- | -- |
| 05/04/2021 | Q1 | -- | $169.2M | $0.32 | -- | -- |
| 02/23/2021 | Q4 | -- | $166.9M | $0.10 | -- | -- |
| 10/28/2020 | Q3 | -- | $151.1M | -$0.24 | -- | -- |
| 08/03/2020 | Q2 | -- | $105.1M | -$0.34 | -- | -- |
| 05/07/2020 | Q1 | -- | $137.3M | $0.04 | -- | -- |
| 02/25/2020 | Q4 | -- | $145.3M | $0.27 | -- | -- |
| 11/07/2019 | Q3 | -- | $139.5M | $0.32 | -- | -- |
| 08/06/2019 | Q2 | -- | $134.2M | $0.46 | -- | -- |
| 05/07/2019 | Q1 | -- | $128.4M | $0.30 | -- | -- |
| 02/26/2019 | Q4 | -- | $120.8M | $0.18 | -- | -- |
| 11/05/2018 | Q3 | -- | $111.8M | -$0.55 | -- | -- |
| 08/07/2018 | Q2 | -- | $109.6M | $0.37 | -- | -- |
| 05/08/2018 | Q1 | -- | $102.7M | $0.15 | -- | -- |
| 02/27/2018 | Q4 | -- | $96.1M | $0.25 | -- | -- |
| 11/07/2017 | Q3 | -- | $83.9M | $0.01 | -- | -- |
| 08/08/2017 | Q2 | -- | $80.6M | -$0.05 | -- | -- |
| 03/31/2017 | Q1 | -- | $73.2M | -$0.10 | -- | -- |
| 12/31/2016 | Q4 | -- | $73.1M | -$0.08 | -- | -- |
| 09/30/2016 | Q3 | -- | $67.2M | $0.35 | -- | -- |
| 06/30/2016 | Q2 | -- | $65.1M | $0.09 | -- | -- |
| 03/31/2016 | Q1 | -- | $57.9M | $0.07 | -- | -- |
Penumbra, Inc. Earnings Questions
-
How Much did Penumbra, Inc. Generate in Revenue Last Quarter?
Penumbra, Inc. reported $354.7M worth of top line sales in its most recent quarter.
-
Did Penumbra, Inc. Beat Earnings Last Quarter?
Penumbra, Inc. announced earnings per share of $1.17 which represents a beat of analyst forecast a $0.92 per share.
-
Is Penumbra, Inc. Profitable?
Penumbra, Inc. reported $238M that represents $6.06 per share over the last quarter.
-
What is the Analyst Consensus for Penumbra, Inc. EPS Next Year?
Penumbra, Inc.'s earnings are forecast to grow from $0.36 per share to $3.77 per share next year representing an increase of 1304.76%.
-
When is Penumbra, Inc.'s Earnings Date?
Penumbra, Inc.'s next earnings date is February 17, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
80
BNR alert for Jan 16
Burning Rock Biotech Ltd. [BNR] is down 4.26% over the past day.
Buy
90
PEN alert for Jan 16
Penumbra, Inc. [PEN] is up 0.25% over the past day.
Buy
100
TLN alert for Jan 16
Talen Energy Corp. [TLN] is down 7.93% over the past day.
